EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Features of cancer in older adults, low immune defense, and modern approaches to individualized treatment

Damir A. Enikeev, Ekaterina A. Degtyaryova, Aleksandr T. Gergaia, Mariia V. Dolnikova, Viktoria A. Teterina, Aslan I. Ismailov, Maria A. Atoyan, Alina A. Shevchenko, Angelina S. Nerukh, Elizaveta A. Sudakova, Anastasia A. Uskova, Anzhela R. Mkrtchyan

Russian Journal of Oncology · 03.05.2026 · 31 (1) · 54-71

DOI: 10.17816/onco706031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Russian Journal of Oncology, online erschienen am 03.05.2026. Verfasst von Damir A. Enikeev und 11 weiteren Autor:innen. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancers in older and elderly adults constitute the majority of oncological cases worldwide; however, research on this age group remains insufficiently covered in randomized clinical trials. The main reason is the natural restructuring of the immune system, but its systemic molecular-clinical analysis remained fragmentary in geriatric oncology for a long time. This review analyzes modern data on the molecular-cellular mechanisms of immunosenescence, inflammatory aging, and how these processes affect tumor development. The search was conducted in six databases (PubMed/MEDLINE, ScienceDirect, Google Scholar, eLIBRARY.ru, CyberLeninka) for the period 2020–2026; 82 sources were included in the final analysis. Available data show that aging and chronic smoldering inflammation help create conditions within the tumor that prevent the immune system from fighting cancer. This is associated with decreased diversity of the T-cell receptor repertoire, accumulation of SASP-secreting senescent cells that maintain low-grade inflammation, and a shift in macrophage polarization toward the M2 phenotype. Nosological analysis revealed that these changes manifest differently in various types of cancer, such as papillary thyroid cancer, glioblastoma, breast cancer, and tumors of the gastrointestinal tract. Therefore, it is important to consider tumor-specific features when treating older adults. Furthermore, according to research data, drugs aimed at enhancing the immune response work approximately equally in young and older patients for the majority of cancer types. However, older adults have a higher risk of side effects, and limited data are available for some patient groups, which complicates the definitiveness of conclusions.

Zitieren

APA

Enikeev, D. A., Degtyaryova, E. A., Gergaia, A. T., Dolnikova, M. V., Teterina, V. A., Ismailov, A. I., Atoyan, M. A., Shevchenko, A. A., Nerukh, A. S., Sudakova, E. A., Uskova, A. A., & Mkrtchyan, A. R. (2026). Features of cancer in older adults, low immune defense, and modern approaches to individualized treatment. Russian Journal of Oncology, 31(1), 54-71. https://doi.org/10.17816/onco706031

Vancouver

Enikeev DA, Degtyaryova EA, Gergaia AT, Dolnikova MV, Teterina VA, Ismailov AI, et al. Features of cancer in older adults, low immune defense, and modern approaches to individualized treatment. Russian Journal of Oncology. 2026;31(1):54-71. doi:10.17816/onco706031

BibTeX
@article{Enikeev2026,
  author = {Enikeev, Damir A. and Degtyaryova, Ekaterina A. and Gergaia, Aleksandr T. and Dolnikova, Mariia V. and Teterina, Viktoria A. and Ismailov, Aslan I. and Atoyan, Maria A. and Shevchenko, Alina A. and Nerukh, Angelina S. and Sudakova, Elizaveta A. and Uskova, Anastasia A. and Mkrtchyan, Anzhela R.},
  title = {Features of cancer in older adults, low immune defense, and modern approaches to individualized treatment},
  journal = {Russian Journal of Oncology},
  year = {2026},
  volume = {31},
  number = {1},
  pages = {54--71},
  doi = {10.17816/onco706031}
}
Kostenlos starten →